글로벌 제약회사에서 신약 파이프라인의 new drug asset을 담당할 Medical portfolio review lead를 채용합니다. Medical affairs / Medical advisor / CR Physician / Clinical Research에 대한 경험을 바탕으로, 메디칼 관점에서 신약 포트폴리오를 리딩할 역량있는 분들의 많은 관심 바랍니다.

- Responsible for accelerating new asset on New Molecular Entities (NMEs) and Line Extensions (LEs). - Continuously acquire and update necessary scientific knowledge on disease area and relevant compounds. - Collaborate with clinical operation teams by providing medical input into the study protocol/feasibility/site selection - RWD/RWE strategy and generation: Align data requirements for registration, access, and reimbursement with RA, Market Access, and Commercial.

- Medical Doctor, PharmD/PhD (Medicine, Pharmacy, Life science/Biology/Chemical/Healthcare-related) - Solid experienced in medical affairs/medical advisor/clinical operation/medical portfolio review of pharmaceutical industry - Excellent understanding drug development and medical/scientific knowledge of related TAs including Oncology, CV, Diabetes, Respiratory, Immunology etc.

- 제약기업 Medical Advisor/Clinical Research Physician 경험자 - New drug pipeline portfolio management - High proficient in English (written & spoken)

서류전형 - 면접전형 - 처우 및 검증 - 입사 [제출 및 문의처] 담당 컨설턴트 / (주)유니코써치 Email:

[email protected]